Organisation paid for research Program year 2021 Source: CMS Open Payments

Accel CLNC Rsrch

Neither a doctor nor a teaching hospital

Research payments

$485,879

92 payments

Through program year 2021, Accel CLNC Rsrch is reported as receiving $485,879 in research payments, across 92 payments.

By program year

2 rows

Year	Kind	Amount	Payments
2021	Research	$12,328	3
2020	Research	$473,551	89

Breakdown

Who paid Research payments · program years 2020–2021

Janssen Research & Development, LLC $485,879 92 payments

Studies the money was for Research payments · program years 2020–2021

A Phase II, Randomized, Double-Blind, Placebo-Controlled Study of Bermekimab in Patients with Moderate to Severe Hidradenitis Suppurativa $463,851 87 payments
A Phase II Randomized Double Blind Placebo Controlled Study of Bermekimab in Patients with Moderate to Severe Hidradenitis Suppurativa $11,078 2 payments
Dermatitis A Phase II, Randomized, Double-Blind, Placebo-Controlled Study of Bermekimab in Patients with Moderate to Severe Atopic Dermatitis $9,700 2 payments
Dermatitis A Phase II Randomized Double Blind Placebo Controlled Study of Bermekimab in Patients with Moderate to Severe Atopic Dermatitis $1,250 1 payment

What you are looking at

A noncovered recipient is an organisation paid for research that is neither an individual clinician nor a teaching hospital — typically a contract research organisation, a foundation or a trial site network. They receive 81% of all reported research money, which is why they appear here at all.